GP NURMENKARI INC 22 Elizabeth Street Norwalk, CT 06854 TEL: 212-400-6993 FAX: 212-247-1059 Member: FINRA & SIPCPlacement Agent Agreement • June 9th, 2025 • Synaptogenix, Inc. • Pharmaceutical preparations • New York
GP NURMENKARI INCPlacement Agent Agreement • September 11th, 2024 • Synaptogenix, Inc. • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes our understanding with respect to the engagement of GP Nurmenkari Inc (“GPN”), registered broker dealer and member of the Financial Industry Regulatory Authority (“FINRA”) and SIPC, and Synaptogenix, Inc., a publicly traded corporation duly organized under the laws of the State of Delaware (the “Company”), to act as a non-exclusive placement agent (the “Placement Agent”) in connection with a (i) registered direct offering pursuant to an effective “shelf” registration statement by the Company of its securities and (ii) a concurrent private placement (collectively, the “Offering”). The Offering is currently anticipated to be an offering of shares of convertible preferred stock of the Company and warrants to purchase shares of common stock of the Company (collectively, the “Securities”). The Company intends to raise up to Five Million Dollars ($5,000,000) (the “Maximum Offering Amount”) through the sale of the Securities. The Company reserves the